Clinical Trials Logo

Advanced Cervical Cancer clinical trials

View clinical trials related to Advanced Cervical Cancer.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT05068921 Recruiting - Clinical trials for Advanced Cervical Cancer

A Clinical Trial to Evaluate Tolerability and Pharmacokinetics of TQB2858 Injection in Subjects With Advanced Malignancy

Start date: December 9, 2021
Phase: Phase 1
Study type: Interventional

A phase I clinical trial of tolerability and pharmacokinetics of TQB2858 injection in subjects with advanced malignancy.

NCT ID: NCT04731038 Recruiting - Clinical trials for Advanced Cervical Cancer

Combination Therapy for First Line Treatment of Advanced Cervical Cancer

Start date: August 1, 2021
Phase: Phase 1
Study type: Interventional

This is a single center phase 1 trail to observe safety and efficacy of Paclitaxel plus Cisplatin\Carboplatin, PD-L1 antibody Toripalimab and Anlotinib as first-line regimen to treat the patient with metastatic 、persistent or recurrent disease after radical surgery、radical platinum-based concurrent chemoradiotherapy or both (Stage IA-IVA).

NCT ID: NCT04508686 Recruiting - Clinical trials for Advanced Cervical Cancer

Combination of Metronomic Capecitabine With Camrelizumab for Treatment of Refractory Solid Tumor Trial (Cohort 1)

Start date: August 1, 2020
Phase: Phase 1
Study type: Interventional

This is a single center phase 1 trail to observe safety and efficacy of metronomic capecitabine plus PD-L1 antibody camrelizumab as third-line regimen to treat HER2 negative advanced gastric cancer patients. This study is one of the cohorts of a multi-cohort trial called Combination of Metronomic capecitabine with Camrelizumab for treatment of refractory solid tumor (McCrest) trial.